Literature DB >> 9537046

Alteration of T-lymphocyte subpopulations in patients with primary renal diseases and systemic lupus erythematosus.

K Matsumoto1, K Osakabe, H Ohi, N Yoshizawa, M Harada, M Hatano.   

Abstract

Forty-eight patients with a variety of primary renal diseases and systemic lupus erythematosus (SLE) were examined for the proportion of circulating T lymphocytes bearing receptors for IgM (T mu cells) or IgG (T gamma cells). Although the control group showed strikingly similar mean values for both T mu and T gamma cells, the whole group of patients with primary renal diseases and SLE showed a wide scatter of values. Sixteen patients with primary renal diseases and SLE had higher proportions of T gamma cells than the control group, whereas seven patients with chronic glomerulonephritis (CGN), membranoproliferative glomerulonephritis (MPGN), lipoid nephrosis (LN), and SLE showed very marked decrease in the proportions of T gamma cells in the peripheral blood. On the other hand, six out of the total group of patients had low proportions of T mu cells in the peripheral blood. However, no consistent relationship between the proportion of T mu and T gamma cells was found in our study. These findings indicate that there exists a heterogeneity of T-lymphocyte subpopulation distribution in some patients with primary renal diseases and SLE. The possible significance of these phenomena in the pathophysiology of renal diseases is discussed.

Entities:  

Mesh:

Year:  1980        PMID: 9537046     DOI: 10.1111/j.1365-3083.1980.tb00226.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Alterations of T cell subpopulations in childhood lipoid nephrosis and its relation to immunosuppressive treatment.

Authors:  X Zhou; Y Q Wang; M T Song
Journal:  Acta Acad Med Wuhan       Date:  1984

2.  Imbalances in peripheral blood T-cell subpopulations in renal transplant patients.

Authors:  G Luciani; N Maggiano; F Citterio; L Lauriola; U Pozzetto; M Piantelli; M Castagneto; P Musiani
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.